Professor Nils Wilking MD PhD has been active in clinical oncology for 30 years after graduating from the Karolinska Institute in Stockholm, Sweden. He has worked for many years in the field of surgical oncology, but has since the late 1980s mainly worked within medical oncology with a focus on breast and GI cancer.
He headed the Breast and GI Cancer Unit at the Karolinska hospital during 1992-1998. During this period, he also set up and headed the clinical trial unit at the Department of Oncology.
In 1998, he joined Eli Lilly as a senior research physician. In 2001, he moved to BMS where he held a European position in their oncology team. Since 2003, he has worked in a research context linked to the Karolinska Institute. Since 2010, he also serves as Senior Strategic Advisor for the Southern Health Care Region in Sweden.
His main focus has been on research in relation to health service delivery. This work, in collaboration with Professor Bengt Jönsson at the Stockholm School of Economics, has resulted in a number of reports with a focus on patient’s access to cancer therapy. These reports include information on more than 55 countries (see www.comparatorreports.se).